Purchases and Sales Made in Q1 2024 in Biomarin Pharmaceutical Inc (BMRN)
This table provides information about the institutional ownership of Biomarin Pharmaceutical Inc (BMRN) during Q1 2024. The information is specifically focused on institutions that hold shares of BIOMARIN PHARMACEUTICAL INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2024
Q1 2024
|
La Banque Postale Asset Management Sa
Paris, I0 |
SELL
|
- |
-225K- 95.73% |
$18.9M - $22.3M
|
10.1K
$677K
|
|
|
May 13, 2024
Q1 2024
|
Natixis
Paris, I0 |
SELL
|
- |
-247K- 85.97% |
$20.7M - $24.5M
|
40.3K
$2.72M
|
|
|
May 13, 2024
Q1 2024
|
Cibc World Markets Corp
New York, NY |
SELL
|
- |
-248K- 91.79% |
$20.8M - $24.6M
|
22.2K
$1.49M
|
|
|
May 15, 2024
Q1 2024
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-293K- 18.64% |
$24.5M - $29M
|
1.28M
$86.1M
|
|
|
May 15, 2024
Q1 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-352K- 81.67% |
$29.5M - $34.9M
|
79.1K
$5.33M
|
|
|
May 15, 2024
Q1 2024
|
Palo Alto Investors LP
Palo Alto, CA |
SELL
|
- |
-366K- 24.4% |
$30.7M - $36.3M
|
1.13M
$76.4M
|
|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-390K- 13.86% |
$32.7M - $38.6M
|
2.42M
$163M
|
|
|
May 14, 2024
Q1 2024
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
SELL
|
- |
-416K- 95.47% |
$34.9M - $41.2M
|
19.8K
$1.33M
|
|
|
May 15, 2024
Q1 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-504K- 31.36% |
$42.2M - $49.9M
|
1.1M
$74.3M
|
|
|
May 14, 2024
Q1 2024
|
1832 Asset Management L.P.
Toronto, A6 |
SELL
|
- |
-718K- 97.32% |
$60.1M - $71M
|
19.7K
$1.33M
|
|
|
May 09, 2024
Q1 2024
|
Parnassus Investments, LLC
|
SELL
|
- |
-976K- 52.79% |
$81.8M - $96.7M
|
873K
$58.8M
|
|
|
May 15, 2024
Q1 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-1.06M- 31.24% |
$89.1M - $105M
|
2.34M
$158M
|
|
|
May 15, 2024
Q1 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-2.09M- 75.04% |
$175M - $207M
|
697K
$46.9M
|
|
|
May 14, 2024
Q1 2024
|
Capital Research Global Investors
Los Angeles, CA |
SELL
|
- |
-4.25M- 39.48% |
$357M - $421M
|
6.52M
$439M
|